Skip to content

A Study on the Application Mechanism of Tuina Techniques Combined with Extracorporeal Shock Wave Therapy for Lumbar and Back Myofascial Pain Syndrome

A Study on the Application Mechanism of Tuina Techniques Combined with Extracorporeal Shock Wave Therapy for Lumbar and Back Myofascial Pain Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002478
Enrollment
Unknown
Registered
2025-12-24
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low back myofascial pain syndrome

Interventions

ESWT Group:Only ESWT Therapy
Tuina Team:Tuina therapy alone
Experimental Group:Tuina therapy combined with ESWT therapy

Sponsors

Shanghai University of Traditional Chinese Medicine Affiliated Yueyang Integrated Chinese and Western Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 4.1 Complies with the clinical diagnostic criteria for myofascial inflammation in "Myofascial Pain and Functional Disorders" and "Chinese Medicine"; 4.2 Age is =18 and =65, with no gender restrictions; 4.3 Imaging examinations exclude other lesions causing low back pain; 4.4 Patients voluntarily sign the informed consent form. 4.5 Patients diagnosed with qi and blood stagnation type according to traditional Chinese medicine.

Exclusion criteria

Exclusion criteria: 5.1 Pregnant or breastfeeding women, patients with mental illness, or those planning pregnancy; 5.2 Patients with severe primary diseases of the cardiovascular, cerebrovascular, liver, or kidney systems; 5.3 Patients who meet diagnostic criteria but also have coagulation disorders or other hematological diseases, as well as diabetes, severe lumbar disc herniation, fractures, or tuberculosis of the bone; 5.4 Patients with skin lesions or infections on the waist and back, or those with a history of thoracolumbar fractures or surgery within the past year; 5.5 Patients who have participated in other drug clinical trials within the past month; 5.7 Patients with a history of malignant tumors; 5.8 Patients with brain trauma, severe cognitive impairment that prevents cooperation, epilepsy, other diseases affecting motor or sensory functions, or those with pacemakers or other implanted medical devices; 5.9 Patients with contraindications for fNIRS monitoring, such as prior cranial surgery, cranial defects, or fear of wearing a skullcap.

Design outcomes

Primary

MeasureTime frame
VAS;

Secondary

MeasureTime frame
Baseline metrics;Lumbar Range of Motion (ROM);Nerve Conduction Velocity (NCV);Somatosensory Evoked Potentials (SSEP);Surface Electromyography (sEMG);Functional magnetic resonance imaging(fMRI);The Short-Form McGill Pain Questionnaire (SF-MPQ);The Pittsburgh Sleep Quality Index (PSQI) ;The Hamilton Anxiety Scale (HAMA);Self-rating depression scale(SDS);Pulmonary Function Indicators;Functional near - infrared spectroscopy(fNIRS);

Countries

China

Contacts

Public ContactZhao Pu

Shanghai University of Traditional Chinese Medicine Affiliated Yueyang Integrated Chinese and Western Medicine Hospital

15221621228@163.com15221621228

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026